Indiana 2020 Regular Session Status: Passed Senate Bipartisan · 3 R · 2 D cosponsors

SB 4 — Health programs.

Last action — Senate advisors appointed: Zay, Randolph Lonnie M, Breaux and Ruckelshaus

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 2020 Regular Session. It reached “Passed Senate” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Summary

Extends the prohibition against the inclusion of certain Medicaid recipients in: (1) risk based managed care programs; or (2) capitated managed care programs; from June 30, 2020, to June 30, 2021. Requires a syringe exchange program to: (1) provide testing for communicable diseases and provide services or a referral for services if the individual tests positive; and (2) establish a referral process for program participants in need of information or education concerning communicable diseases or health care. Requires the state department of health to include certain information concerning syringe exchange programs in the report to the general assembly before November 1, 2020. Extends the expiration date for certain syringe exchange programs from July 1, 2021, to July 1, 2022.

Bill Text

We don't have the full text on file for this bill yet.

Read SB 4 on the official Indiana source →

Action History

  1. Senate advisors appointed: Zay, Randolph Lonnie M, Breaux and Ruckelshaus

  2. Senate conferees appointed: Charbonneau and Melton

  3. Senate dissented from House amendments

  4. House advisors appointed: Barrett, Schaibley and Fleming

  5. House conferees appointed: Kirchhofer and Shackleford

  6. Motion to dissent filed

  7. Returned to the Senate with amendments

  8. Third reading: passed; Roll Call 265: yeas 82, nays 12

  9. Representative Shackleford added as cosponsor

  10. Representative Clere added as cosponsor

  11. Second reading: ordered engrossed

  12. Representative Schaibley added as cosponsor

  13. Representative Kirchhofer removed as cosponsor

  14. Representative Kirchhofer added as sponsor

  15. Representative Schaibley removed as sponsor

  16. Committee report: amend do pass, adopted

  17. First reading: referred to Committee on Public Health

  18. Referred to the House

  19. Cosponsor: Representative Kirchhofer

  20. House sponsor: Representative Schaibley

  21. Third reading: passed; Roll Call 94: yeas 47, nays 3

  22. Senator Randolph added as coauthor

  23. Senator Glick added as coauthor

  24. Second reading: ordered engrossed

  25. Senator Ruckelshaus added as second author

  26. Committee report: amend do pass, adopted

  27. Senator Stoops added as coauthor

  28. Senator Melton added as coauthor

  29. Committee report: amend do pass adopted; reassigned to Committee on Appropriations

  30. First reading: referred to Committee on Health and Provider Services

  31. Authored by Senator Charbonneau

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

3 sponsors · 7 co-sponsors · 140 not signed on

Sponsors (3)

Co-sponsors (7)

Not signed on (140)

140 members have not signed on to this bill.

Show all 140 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB 4 do?
Extends the prohibition against the inclusion of certain Medicaid recipients in: (1) risk based managed care programs; or (2) capitated managed care programs; from June 30, 2020, to June 30, 2021. Requires a syringe exchange program to: (1) provide testing for communicable diseases and provide services or a referral for services if the individual tests positive; and (2) establish a referral process for program participants in need of information or education concerning communicable diseases or health care. Requires the state department of health to include certain information concerning syringe exchange programs in the report to the general assembly before November 1, 2020. Extends the expiration date for certain syringe exchange programs from July 1, 2021, to July 1, 2022.
Who sponsors SB 4?
SB 4 is sponsored by Robin Shackleford (Democrat), Edward Clere (Republican), Donna Schaibley, Cindy Kirchhofer, Lonnie Randolph (Democrat), Susan Glick (Republican), Mark Stoops, Eddie Melton, John Ruckelshaus, and Ed Charbonneau (Republican).
What is the current status of SB 4?
This bill died with 2020 Regular Session. It reached “Passed Senate” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track SB 4?
Track SB 4 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 4

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB 4

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →